Ethyl-EPA (Miraxion) The Huntington Study Group
(HSG) and the European Huntington’s Disease Network (EHDN) announce the
preliminary results of two phase III studies of Ethyl-EPA (Miraxion).
23.05.2007
EHDN annual Meeting for Norwegian and Danish speaking investigators in Oslo, Norway
21.04.2007
JHD Working Group Meeting HDA Head Office, London Bridge, London, U.K. Times and agenda to be confirmed.
19.05.2007
Reunión de la Asociación Española de Huntington. En el Hogar Extremeño, c/ Gran Vía, Madrid. España
26.03.2007
One-day session: Searching Genes of Neurodegenerative Diseases in Isolated Populations, Madrid, Spain
11.05.2007
Deep Brain Stimulation Focus Group meeting as a part of the Surgical Working Group. London, UK
19-20.03.2007
Fourth investigator meeting of the German-speaking study sites in Günzburg
11.05.2007
Face-to-face Meeting of the Cognitive Phenotype working group, in Paris, France.
16.03.2007
for the Symposium on Neuroendocrine Changes in Huntington´s Disease in Leiden, the Netherlands
09.05.2007
EHDN annual Meeting for Swedish speaking investigators in Stockholm, Sweden
16.03.2007
Friday 16 March 2007: Symposium on Neuroendocrine Changes in Huntington´s Disease in Leiden, The Netherlands.
04.-05.05.2007
First investigator meeting of the Czech-speaking study sites in Prague, Czech Republic
09.03.2007
Meeting of the French speaking Investigators (France - Belgium - Switzerland) in Paris, France.
25-26.04.2007
EHDN annual meeting for English-speaking investigators in Cardiff, UK
![[logo]](/html/hd_logo_web_re.gif){kind=logo}
![[+]](/public/pfeil_rechts.gif)
O projecto![[...]](/public/icons/next.gif){kind=icon}